is semaglutide a lifelong drug GLP-1 Drugs and the Physiology of Metabolic Health The Promise of Weight-Loss Drugs

DOI: 10.1080/004982598238976 Johansen PB, Nowak J, Skjaerbaek C, Flyvbjerg A, Andreassen TT, Wilken M, et al

The AMP-Activated Protein KinaseFuel Gauge of the Mammalian Cell

Homologues of human macrophage migration inhibitory factor from a parasitic nematode: gene cloning, protein activity and crystal structure

By leveraging berberine's documented ability to influence cellular energy regulation and glucose metabolism, this botanical product is positioned as an accessible, scientifically backed holistic alternative to naturally manage blood sugar levels and support sustainable wellness without relying solely on synthetic pharmaceuticals In December 2025, Innovent Biologics, a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabolic, ophthalmologic and other major diseases, announces that the results of two Phase III clinical studies of Mazdutide, the world's first approved glucagon (GCG)/glucagon-like peptide-1 (GLP-1) dual receptor agonist, in Chinese adults with type 2 diabetes (T2D) (DREAMS-1, DREAMS-2) have been published back-to-back in Nature as Accelerated Article Previews (AAP)

FukamiKYamagishiS-ISakaiKKaidaYMinamiANakayamaYet al

Optic Labs supplies AOD-9604 as a lyophilised research-grade peptide for laboratories investigating adipocyte lipolysis, 3-adrenergic signalling, and energy-balance pathways